Leadership & Pay ·
Entera Bio appoints Dr. Juan Camilo Arjona Ferreira as director; Haya Taitel steps down
ENTXEntera Bio Ltd.
Entera Bio Ltd. appointed Dr. Juan Camilo Arjona Ferreira, currently Head of R&D and CMO at Organon & Co., to its Board of Directors effective December 1, 2026. He will serve as a Class II director until the 2027 Annual Meeting and join the compensation committee. Dr. Arjona Ferreira succeeds Haya Taitel, who is stepping down from the board. The company operates in the biotechnology sector, developing oral peptide therapies for conditions such as osteoporosis.